The FDA has not identified a stroke risk in seniors who received the Pfizer booster after reviewing multiple federal databases. The FDA also reached out to regulators in Europe and Israel, who did not report an increased risk of stroke. Preliminary CDC data indicated a possible stroke risk following simultaneous...